-
2007-2008: Pharmaceutical registration program consisting of 3 multinational, multi-centre studies (DK, SE, UK)
-
2006-2010: Phase IV multinational multi-centre trial in 51 sites in 4 countries (DK, NO, SE, FI) with 380 patients
-
2004-2009: Phase IV Multinational multi-centre trial in 60 sites in 8 countries (DK,NO,SE,FI,BE,CH,UK,NL) with 384 patients
-
2006-2007: Phase II studies in 4 countries (D, UK, SE and DK) with 12 sites and 40 patients
-
2006-2007: Phase II studies (Orphan drug program) in 3 countries (US, DK and SE) with 5 sites and 30 patients